Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1445556526
总结
CYP2D6 intermediate metabolizers are associated with decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 normal metabolizers.